Skip to main content
Equibles
NAMS logo

NAMS · NewAmsterdam Pharma Co N.V.

Track NAMS — free

Use NAMS with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about NAMS

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$27.40 +0.06 (+0.22%) At close · Aug 26
Market Cap
$3.27B
Shares
119.54M

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

NAMS Short Interest Forecast

Equibles' model estimates 12,644,857 shares sold short for the August 31, 2026 settlement, -0.1% versus the latest reported position. This model prediction uses FINRA data through August 21, 2026; FINRA's official release is expected September 10, 2026.

Model estimate

Expected Aug 31 short interest

as of Aug 21
12,644,857 -0.1% vs reported
The latest estimate appears in the chart below. Official release expected Sep 10. Methodology
Short Squeeze Score
73/100
Short interest 10.6% of shares — P91 Days to cover 9.9 — P90 Price vs VWAP -10.8% — P22 Short-volume trend +8.5% — P78 Short interest change +27.1% — P88 Worst FTD 0.00% of shares — P39

Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-08-14). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.

1M 3M 6M 1Y 5Y All
Dimensions
  • Add to chart

    • Short Interest History

    Settlement Date Current Position Previous Position Change Days to Cover
    2026-09-15 Scheduled
    FINRA publishes Sep 24
    		 — — — —
    2026-08-31 Scheduled
    FINRA publishes Sep 10
    		 — — — —
    2026-08-14 12,654,106 9,959,761 +2,694,345 9.92
    2026-07-31 9,959,761 9,176,420 +783,341 9.77
    2026-07-15 9,176,420 9,091,198 +85,222 11.20
    2026-06-30 9,091,198 9,171,265 -80,067 6.94
    2026-06-15 9,171,265 8,099,601 +1,071,664 7.30
    2026-05-29 8,099,601 7,139,696 +959,905 6.15
    2026-05-15 7,139,696 7,882,443 -742,747 3.72
    2026-04-30 7,882,443 7,682,586 +199,857 8.94
    2026-04-15 7,682,586 8,047,048 -364,462 8.74
    2026-03-31 8,047,048 7,545,738 +501,310 9.63
    2026-03-13 7,545,738 7,658,931 -113,193 7.33
    2026-02-27 7,658,931 6,951,469 +707,462 11.27
    2026-02-13 6,951,469 7,100,900 -149,431 10.67
    2026-01-30 7,100,900 6,319,202 +781,698 13.95
    2026-01-15 6,319,202 6,213,363 +105,839 7.31
    2025-12-31 6,213,363 6,258,439 -45,076 8.35
    2025-12-15 6,258,439 6,677,161 -418,722 5.19
    2025-11-28 6,677,161 6,817,112 -139,951 7.16
    2025-11-14 6,817,112 6,424,987 +392,125 6.23
    2025-10-31 6,424,987 6,855,986 -430,999 6.08
    2025-10-15 6,855,986 7,640,225 -784,239 4.59
    2025-09-30 7,640,225 8,434,726 -794,501 10.07
    2025-09-15 8,434,726 7,497,579 +937,147 6.71
    2025-08-29 7,497,579 7,328,645 +168,934 9.83

    Full FINRA short interest reporting calendar

    Showing 1–24 of 24 settlements
    Key facts CIK 1936258 CUSIP N62509109 13F (30d) 178 filings 176 filers Visit website Investor relations

    Report a Problem

    Category
    Description
    Email (optional, for follow-up)